▁Chron 9.2890625
ic 0.54833984375
▁pain 2.763671875
▁is 1.1630859375
▁still 6.71484375
▁considered 3.98828125
▁to 1.9228515625
▁be 0.0328369140625
▁an 2.6796875
▁extreme 7.2578125
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.1561279296875
▁ 0.390380859375
8 3.474609375
% 2.189453125
▁of 0.1221923828125
▁the 0.52001953125
▁residents 6.63671875
▁of 0.73876953125
▁progress 12.65625
ive 0.319580078125
▁countries 0.91796875
. 0.6357421875
▁The 2.12109375
▁introduction 7.75
▁of 0.031005859375
▁the 2.357421875
▁study 7.31640625
▁describes 7.28125
▁the 0.57568359375
▁apparent 8.9140625
▁link 4.6875
▁between 0.2430419921875
▁pain 2.712890625
▁and 0.296142578125
▁dem 7.140625
oral 3.390625
ization 0.12176513671875
. 1.046875
▁Chron 4.515625
ic 0.003231048583984375
▁pain 0.1103515625
▁is 1.095703125
▁always 5.60546875
▁accompanied 2.982421875
▁by 0.1500244140625
▁negative 4.15234375
▁emot 0.912109375
ional 1.4072265625
▁experiences 2.984375
▁and 2.078125
▁blocks 11.296875
▁a 3.345703125
▁person 0.69091796875
’ 0.876953125
s 0.0010824203491210938
▁ability 1.3916015625
▁to 0.037261962890625
▁receive 6.84765625
▁joy 3.732421875
▁and 1.3818359375
▁satisfaction 3.26171875
▁from 0.86572265625
▁life 0.7919921875
. 0.22802734375
▁The 1.646484375
▁research 2.69140625
▁investig 5.40234375
ates 0.386962890625
▁the 0.38818359375
▁development 6.15234375
▁of 0.145751953125
▁de 3.84765625
pression 0.458251953125
▁and 1.359375
▁anx 1.6201171875
iety 0.0010976791381835938
▁among 1.603515625
▁patients 1.4833984375
▁receiving 5.83203125
▁ph 5.48046875
arma 3.2109375
ce 0.012176513671875
ut 6.520748138427734e-05
ical 0.00652313232421875
▁op 4.64453125
io 0.09844970703125
ids 0.44580078125
▁and 2.494140625
▁medical 4.05859375
▁mar 1.755859375
iju 0.0010738372802734375
ana 4.851818084716797e-05
▁( 2.9453125
MM 1.2958984375
) 2.900390625
▁as 2.427734375
▁severe 9.9921875
▁pain 0.78271484375
kill 2.65625
ers 0.0005288124084472656
. 0.2161865234375
▁It 3.2578125
▁comp 4.98046875
ares 0.0084686279296875
▁the 0.59033203125
▁effic 4.296875
acy 0.0018529891967773438
▁of 0.2066650390625
▁pres 6.0859375
cri 1.9169921875
ptions 1.451171875
▁and 1.927734375
▁exam 4.49609375
ines 0.00981903076171875
▁the 0.473388671875
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.5849609375
tre 1.96875
at 0.0017948150634765625
ment 0.004730224609375
▁de 1.642578125
pression 0.08135986328125
. 1.38671875
<0x0A> 0.77099609375
There 4.6640625
▁is 1.1787109375
▁currently 5.546875
▁a 1.0595703125
▁severe 4.9296875
▁lack 1.8564453125
▁of 0.014617919921875
▁information 2.27734375
▁about 1.162109375
▁the 0.47021484375
▁effects 3.1015625
▁of 0.0631103515625
▁op 3.076171875
i 3.6953125
ates 0.01168060302734375
. 3.380859375
▁They 4.52734375
▁manage 8.40625
▁pain 3.388671875
▁successfully 5.81640625
, 0.974609375
▁but 0.237548828125
▁the 2.482421875
▁past 9.0546875
▁few 2.248046875
▁dec 1.248046875
ades 0.0006265640258789062
▁indicated 7.0078125
▁the 1.73828125
▁growing 3.60546875
▁concern 3.380859375
▁regarding 2.716796875
▁op 2.5546875
iate 1.08984375
▁ab 1.58984375
use 0.01508331298828125
▁in 3.822265625
▁forms 8.859375
▁of 0.2509765625
▁over 3.2890625
d 0.1043701171875
ose 0.32666015625
▁and 0.701171875
▁add 0.701171875
iction 0.01934814453125
. 0.1365966796875
▁A 4.03515625
▁more 4.796875
▁manage 7.921875
able 0.0005059242248535156
▁and 2.109375
▁sa 2.064453125
fer 0.00015425682067871094
▁alternative 1.3193359375
▁might 5.11328125
▁be 0.11871337890625
▁medical 1.580078125
▁mar 0.1561279296875
iju 0.0006961822509765625
ana 9.655952453613281e-05
. 0.94921875
▁However 3.326171875
, 0.0025386810302734375
▁the 1.6845703125
▁legal 3.943359375
▁status 1.1416015625
▁and 3.12890625
▁novel 9.84375
ty 0.1326904296875
▁of 0.1466064453125
▁this 2.328125
▁drug 1.37890625
▁do 4.36328125
▁not 0.01226043701171875
▁allow 0.6982421875
▁finding 6.9140625
▁a 2.38671875
▁large 2.568359375
▁number 0.7880859375
▁of 0.00208282470703125
▁studies 1.2880859375
▁on 1.7666015625
▁its 0.7998046875
▁effect 2.36328125
iveness 0.1767578125
. 0.64013671875
▁Specifically 8.9765625
, 0.046844482421875
▁it 2.6328125
▁concerns 5.06640625
▁the 0.81640625
▁emot 6.5625
ional 0.01873779296875
▁condition 4.6015625
▁of 0.218505859375
▁patients 0.68017578125
▁experien 5.25
cing 1.633167266845703e-05
▁chron 0.80908203125
ic 0.0003528594970703125
▁pain 0.05035400390625
. 0.43212890625
▁This 2.923828125
▁research 1.8876953125
▁paper 4.05078125
▁a 1.83203125
ims 0.00051116943359375
▁to 0.11553955078125
▁analyze 3.291015625
▁levels 9.9296875
▁of 0.020843505859375
▁de 0.493896484375
pression 0.023956298828125
▁and 0.1829833984375
▁anx 0.0237274169921875
iety 0.0004162788391113281
▁among 0.7509765625
▁people 2.48828125
▁receiving 2.236328125
▁ther 6.6171875
apy 0.10516357421875
▁by 4.55078125
▁comparing 8.8515625
▁the 1.53125
▁effects 2.150390625
▁of 0.023895263671875
▁ph 2.943359375
arma 0.0309295654296875
ce 0.0031757354736328125
ut 9.882450103759766e-05
ical 0.0035457611083984375
▁op 0.11798095703125
io 0.61865234375
ids 0.0305633544921875
▁and 0.2413330078125
▁MM 0.476318359375
. 0.253173828125
<0x0A> 0.449951171875
The 0.748046875
▁study 1.7197265625
▁was 2.32421875
▁conducted 0.64794921875
▁in 1.24609375
▁the 1.4013671875
▁form 2.5703125
▁of 0.0017671585083007812
▁collection 11.796875
▁and 0.666015625
▁analysis 0.38671875
▁of 0.00920867919921875
▁statistical 3.814453125
▁data 0.11712646484375
. 0.875
▁Part 5.21875
icip 0.2442626953125
ants 0.061920166015625
▁were 0.6943359375
▁rec 3.564453125
ru 0.0007967948913574219
ited 0.00026345252990722656
▁for 4.05859375
▁six 6.83984375
▁months 0.473876953125
▁at 3.76953125
▁two 2.591796875
▁major 3.912109375
▁pain 2.681640625
▁relief 4.15234375
▁cent 0.8447265625
ers 0.025665283203125
▁in 0.65478515625
▁Israel 5.5078125
. 0.326416015625
▁The 1.2109375
▁research 2.404296875
ers 1.361328125
▁used 2.21875
▁The 7.125
▁De 2.94140625
pression 0.022125244140625
▁Module 6.71875
▁of 0.71630859375
▁the 0.2218017578125
▁Pat 3.294921875
ient 0.00891876220703125
▁Health 0.031951904296875
▁Question 0.0179443359375
naire 0.0247039794921875
▁and 2.732421875
▁the 0.853515625
▁General 1.20703125
ized 0.61328125
▁An 0.0048065185546875
x 8.71419906616211e-05
iety 0.0003941059112548828
▁Dis 0.1812744140625
order 0.0196533203125
▁Sc 1.4404296875
ale 0.0027141571044921875
▁to 0.912109375
▁interview 7.60546875
▁participants 2.75
, 4.35546875
▁evaluate 4.5234375
▁their 0.53759765625
▁answers 4.2265625
, 0.320068359375
▁and 0.033935546875
▁conduct 5.015625
▁the 1.82421875
▁study 2.435546875
. 0.099609375
▁To 4.81640625
▁specifically 9.9296875
▁evaluate 3.3046875
▁and 5.109375
▁compare 0.505859375
▁the 0.399169921875
▁prob 9.96875
abilities 0.057830810546875
▁of 0.0694580078125
▁de 0.857421875
pression 0.0345458984375
▁or 4.4140625
▁anx 0.045806884765625
iety 0.0005865097045898438
▁among 1.373046875
▁the 2.1640625
▁diverse 9.7421875
▁groups 0.78857421875
, 0.78076171875
▁the 0.422607421875
▁study 2.767578125
▁used 1.33203125
▁multiple 5.37109375
▁log 0.61376953125
istic 0.025543212890625
▁regression 0.27978515625
▁analysis 1.3359375
▁and 2.80859375
▁chose 8.5546875
▁medical 6.18359375
▁mar 0.08929443359375
iju 0.0009760856628417969
ana 4.589557647705078e-05
▁as 0.5595703125
▁the 0.90087890625
▁control 2.87109375
▁group 0.623046875
. 0.266357421875
<0x0A> 0.432373046875
This 4.1640625
▁type 6.26171875
▁of 0.002017974853515625
▁study 1.3583984375
▁is 1.3623046875
▁the 3.74609375
▁most 1.306640625
▁reve 8.140625
aling 0.0005106925964355469
▁and 1.5087890625
▁inclus 6.9296875
ive 0.0007805824279785156
, 3.189453125
▁as 1.2685546875
▁it 0.341552734375
▁contains 4.640625
▁direct 5.95703125
▁responses 5.59375
▁from 0.5703125
▁a 3.462890625
▁large 0.89306640625
▁number 0.47265625
▁of 0.002666473388671875
▁participants 0.99658203125
. 0.6064453125
▁All 5.33203125
▁tools 7.953125
▁in 5.78515625
▁the 0.794921875
▁form 4.01171875
▁of 0.01551055908203125
▁question 0.66162109375
na 0.01374053955078125
ires 0.0002925395965576172
▁and 1.193359375
▁scales 2.552734375
▁have 3.4453125
▁already 3.998046875
▁been 0.38916015625
▁used 2.263671875
▁and 1.75390625
▁proved 2.34375
▁their 1.38671875
▁effic 2.552734375
acy 0.0030498504638671875
▁for 3.5625
▁collect 4.01953125
ing 0.0035839080810546875
▁analyt 7.21875
ical 0.09442138671875
▁data 0.1876220703125
. 0.367431640625
▁It 3.353515625
▁helps 4.19921875
▁to 0.64013671875
▁system 6.8671875
at 0.60009765625
ize 0.0016107559204101562
▁and 1.30078125
▁class 4.796875
ify 0.0017042160034179688
▁distinct 8.3046875
▁kinds 6.36328125
▁of 0.0156402587890625
▁information 2.123046875
▁for 4.0078125
▁subsequent 5.09765625
▁un 8.71875
comp 4.4375
licated 0.026885986328125
▁services 12.4921875
. 0.595703125
▁Thus 4.828125
, 0.00485992431640625
▁research 4.37109375
ers 0.2369384765625
▁can 1.6396484375
▁compare 2.685546875
▁the 1.03125
▁effects 2.85546875
▁of 0.09552001953125
▁medic 3.72265625
ations 0.64306640625
▁on 1.669921875
▁patients 2.046875
▁of 4.171875
▁diverse 3.076171875
▁age 1.9619140625
▁groups 2.171875
, 0.72412109375
▁background 3.76953125
s 0.12213134765625
, 0.01611328125
▁physical 5.6171875
▁conditions 1.271484375
, 0.03515625
▁emot 6.39453125
ional 0.0257720947265625
▁states 1.2978515625
, 0.0418701171875
▁and 0.391845703125
▁so 2.5078125
▁on 0.1845703125
. 0.067138671875
<0x0A> 0.81298828125
The 0.70556640625
▁analysis 3.912109375
▁of 0.69970703125
▁a 5.7578125
▁human 9.0234375
▁reaction 4.80859375
▁has 5.87109375
▁a 2.04296875
▁high 2.990234375
▁potential 3.23046875
▁for 0.7939453125
▁bias 5.5234375
. 0.92333984375
<0x0A> 5.87109375
Of 7.7890625
▁the 1.7705078125
▁ 0.8603515625
8 3.068359375
9 2.5390625
0 2.884765625
▁participants 1.2099609375
, 0.423828125
▁ 0.29833984375
4 1.7216796875
7 2.384765625
4 2.869140625
▁were 1.1884765625
▁treated 3.0
▁sole 6.5703125
ly 0.0003020763397216797
▁with 0.30322265625
▁op 1.244140625
io 0.396728515625
ids 0.1099853515625
, 0.43505859375
▁ 0.96484375
3 1.23046875
2 2.240234375
9 2.47265625
▁were 1.818359375
▁treated 0.9033203125
▁with 0.266845703125
▁MM 0.449462890625
, 0.310302734375
▁and 0.1142578125
▁ 0.2349853515625
7 2.78125
7 0.8583984375
▁were 0.9052734375
▁treated 0.5517578125
▁with 0.1085205078125
▁place 8.265625
bo 0.5185546875
. 0.33251953125
<0x0A> 2.61328125
The 1.05859375
▁study 2.23046875
▁conducted 4.87109375
▁a 2.240234375
▁correlation 6.08984375
▁type 9.78125
▁of 0.279541015625
▁research 1.4189453125
▁with 3.572265625
▁variable 8.34375
▁measures 4.953125
. 0.951171875
▁It 1.736328125
▁evaluated 4.82421875
▁the 0.53955078125
▁inter 6.05078125
dep 2.333984375
end 0.0001475811004638672
ence 0.0059661865234375
▁of 0.52197265625
▁various 3.537109375
▁factors 0.8525390625
▁that 2.830078125
▁affected 3.8828125
▁the 0.376708984375
▁physical 6.46484375
▁and 0.318603515625
▁emot 0.492431640625
ional 0.0001392364501953125
▁condition 1.6845703125
▁of 0.03863525390625
▁patients 0.935546875
▁experien 3.427734375
cing 8.034706115722656e-05
▁chron 0.23583984375
ic 0.00021791458129882812
▁pain 0.0189056396484375
. 0.0897216796875
▁For 4.48046875
▁example 1.140625
, 0.0016231536865234375
▁the 0.990234375
▁survey 6.49609375
▁showed 3.611328125
▁that 0.36181640625
▁the 1.73828125
▁ratio 6.75390625
▁of 0.081787109375
▁female 3.453125
▁patients 0.9814453125
▁was 1.166015625
▁remark 8.1875
ably 0.00014972686767578125
▁higher 0.1800537109375
▁in 2.22265625
▁the 0.42138671875
▁op 3.033203125
i 2.8671875
ates 0.01250457763671875
▁group 0.142333984375
▁compared 2.529296875
▁to 0.0809326171875
▁the 0.6171875
▁MM 0.1669921875
▁group 0.343017578125
. 0.24365234375
▁In 3.337890625
▁turn 3.404296875
, 0.0009551048278808594
▁people 4.88671875
▁on 5.0
▁op 2.69140625
i 0.46630859375
ates 0.0054473876953125
▁were 0.8525390625
▁more 1.5048828125
▁likely 0.23779296875
▁to 0.0240631103515625
▁report 2.845703125
▁major 6.3046875
▁de 0.38232421875
press 0.89111328125
ive 0.0034580230712890625
▁dis 0.9052734375
orders 1.5517578125
. 1.5771484375
<0x0A> 1.6494140625
The 0.8857421875
▁variables 7.43359375
▁used 2.666015625
▁to 2.201171875
▁collect 3.375
▁information 1.8701171875
▁were 1.513671875
▁gender 3.65625
, 0.088134765625
▁age 0.54541015625
, 0.04644775390625
▁country 5.02734375
, 2.83203125
▁type 3.115234375
▁of 0.037811279296875
▁residence 5.96484375
, 0.12103271484375
▁and 1.7451171875
▁years 5.62890625
▁of 0.283935546875
▁education 1.962890625
. 0.10528564453125
<0x0A> 1.962890625
Am 5.46484375
ong 0.00396728515625
▁all 2.34765625
▁participants 1.763671875
▁in 3.7421875
▁the 0.184326171875
▁study 0.73095703125
, 0.050750732421875
▁ 0.98095703125
4 1.884765625
2 2.4296875
. 0.84619140625
2 2.2109375
% 0.132080078125
▁suffered 3.8984375
▁from 0.043304443359375
▁de 1.439453125
pression 0.1029052734375
, 0.90673828125
▁and 1.0107421875
▁ 0.1165771484375
3 1.3017578125
7 2.33984375
% 2.625
▁experienced 2.103515625
▁excess 6.96875
ive 0.0264892578125
▁anx 0.2410888671875
iety 0.0015926361083984375
. 0.1396484375
▁The 2.130859375
▁pl 11.0234375
ur 0.60498046875
ality 0.0007777214050292969
▁of 0.11309814453125
▁de 2.560546875
press 1.685546875
ive 0.0684814453125
▁dis 2.1171875
orders 0.06658935546875
▁among 2.873046875
▁patients 1.505859375
▁in 2.966796875
▁the 0.2666015625
▁op 0.427734375
i 0.39306640625
ates 0.0015354156494140625
, 9.0390625
▁medical 4.46484375
▁mar 0.035675048828125
iju 0.0007448196411132812
ana 4.756450653076172e-05
, 0.11224365234375
▁and 0.035980224609375
▁mixed 7.1328125
▁OP 11.7890625
MM 4.9609375
▁groups 0.48779296875
▁number 9.265625
ed 0.020660400390625
▁ 0.179443359375
5 2.044921875
7 2.626953125
. 0.3798828125
1 2.482421875
%, 0.1900634765625
▁ 0.00322723388671875
2 1.818359375
2 2.54296875
. 0.09381103515625
3 2.259765625
%, 0.043487548828125
▁and 0.044281005859375
▁ 0.0016546249389648438
5 2.326171875
1 1.998046875
. 0.1507568359375
4 1.5400390625
%, 0.1385498046875
▁respectively 0.0247955322265625
. 0.048980712890625
▁The 1.3994140625
▁pl 3.701171875
ur 0.0094451904296875
ality 9.059906005859375e-05
▁of 0.03240966796875
▁anx 0.466064453125
iety 0.0216064453125
▁contained 10.7109375
▁ 0.2213134765625
4 1.19921875
8 2.314453125
. 0.1668701171875
4 2.20703125
% 2.244140625
▁among 2.50390625
▁OP 5.0390625
▁patients 5.70703125
, 0.267578125
▁ 0.0828857421875
2 0.970703125
1 2.484375
. 0.1109619140625
5 2.0625
% 0.021484375
▁among 0.4501953125
▁MM 0.10345458984375
▁patients 0.324462890625
, 0.0173492431640625
▁and 0.01446533203125
▁ 0.0215911865234375
3 1.5
8 1.9521484375
. 0.1239013671875
7 2.509765625
% 0.0118255615234375
▁among 0.1995849609375
▁OP 2.14453125
MM 0.1495361328125
▁participants 3.74609375
. 0.03472900390625
▁Pat 6.19140625
ients 0.0163116455078125
▁who 2.25
▁took 3.02734375
▁strong 10.15625
▁op 0.6240234375
i 0.80615234375
ates 0.0038585662841796875
▁were 1.2529296875
▁t 10.234375
ended 1.095703125
▁to 0.00939178466796875
▁place 9.90625
▁their 3.01953125
▁pain 3.70703125
▁on 1.6435546875
▁a 0.78369140625
▁scale 2.240234375
▁of 0.333984375
▁ 0.17333984375
9 2.19140625
▁to 2.21484375
▁ 0.01169586181640625
1 0.0075225830078125
0 0.04608154296875
▁( 3.078125
Fe 10.2578125
ing 2.681640625
old 0.73583984375
▁et 1.5830078125
▁al 0.015655517578125
., 0.1329345703125
▁ 0.0157012939453125
2 0.06488037109375
0 0.00021255016326904297
1 0.27734375
7 1.7275390625
). 0.063720703125
▁They 4.4140625
▁were 1.65234375
▁also 1.1416015625
▁an 9.625
gu 4.39453125
ished 0.0643310546875
▁em 6.34375
otion 0.0009264945983886719
ally 0.00046753883361816406
▁and 1.048828125
▁react 7.3359375
ed 0.0186614990234375
▁rad 9.09375
ically 0.0009107589721679688
▁neg 5.15625
atively 0.001308441162109375
▁to 0.193603515625
▁almost 5.8671875
▁all 1.509765625
▁survey 4.96484375
▁questions 0.345947265625
. 0.3427734375
▁Pat 3.466796875
ients 0.005615234375
▁who 1.2509765625
▁took 1.5263671875
▁only 5.12109375
▁MM 0.295166015625
▁or 2.3984375
▁mixed 1.9375
▁medic 1.6904296875
ations 0.3408203125
▁course 13.7890625
▁had 2.634765625
▁a 1.3349609375
▁significantly 2.935546875
▁more 2.818359375
▁stable 3.701171875
▁emot 0.93994140625
ional 0.0009899139404296875
▁state 0.552734375
▁and 1.28125
▁cop 6.72265625
ed 0.02618408203125
▁with 0.374267578125
▁pain 0.9892578125
▁more 1.7919921875
▁manage 6.91015625
able 1.7275390625
. 0.36279296875
<0x0A> 0.42822265625
The 0.8564453125
▁high 6.06640625
▁response 6.32421875
▁rate 0.2437744140625
▁is 2.564453125
▁due 3.78125
▁to 0.01129150390625
▁the 0.266357421875
▁weak 11.0703125
▁focus 6.78515625
▁of 1.15234375
▁respond 6.640625
ents 0.0660400390625
▁who 4.21875
▁have 3.52734375
▁overcome 7.625
▁severe 2.716796875
▁pain 0.71923828125
▁sens 8.125
ations 0.23388671875
▁and 1.2041015625
▁de 4.703125
pression 0.471923828125
. 0.65478515625
